12th International Congress of TDM & Clinical Toxicology
October 2 - 6, 2011
Stuttgart Germany
View photos from the Congress!

Foster and promote education and research in therapeutic drug monitoring and clinical toxicology;

Improve the standards of practice and clinical interpretation of drug and toxic substance analyses and facilitate the delivery of interpretation through clinical pharmacokinetics and toxicokinetics for enhanced patient care;

Encourage cooperation with and among members of all professions concerned with TDM and clinical toxicology;

Encourage the effective application of therapeutic drug monitoring to optimize clinical drug use and maximize the clinical and economic benefits;

Encourage progress in clinical toxicology as a diagnostic tool and therapeutic aid for therapeutic drug overdoses, drug abuse, and exposure to environmental toxicants.

Application form (PDF)

Definition of TDM

Therapeutic Drug Monitoring is the official journal of IATDMCT

IATDMCT members have free on-line access to the journal Therapeutic Drug Monitoring.

Instructions for authors

IFCC-IATDMCT Working Group on Immunosuppressive Drug Monitoring Workshop and Annual General meeting, Los Angeles, July 2004

Faculty from the IFCC-IATDMCT Working Group on Immunosuppressive Drug Monitoring Workshop.From left to right): Prof Gilbert Burckhart, University of Southern California, Los Angeles, USA, Prof Les Shaw, University of Pennsylvania, Philadelphia, USA, Dr. Belinda Yen-Lieberman, Cleveland Clinic, Cleveland, USA, Dr. David Holt, St. George's Hospital Medical School, London, UK, Dr. Ray Morris, Queen Elizabeth Hospital, Woodville, Australia